Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Anthony Elias and Radhika Acharya-Leon.

 
Connection Strength
 
 
 
0.062
 
  1. O'Sullivan CC, Kalinsky KM, Yau C, Kulkarni T, Yee D, Wallace AM, Chien AJ, Boughey JC, Elias AD, Nanda R, Isaacs C, Omene C, Stringer-Reasor E, Clark AS, Thomas A, Han HS, Chan N, Williams N, Trivedi MS, Arora M, Vaklavas C, Tseng J, Bommakanti S, Anampa Mesias JD, Zimmer A, Falkson C, Torres ER, Nangia C, Albain KS, Rozenblit M, Zare S, Fazelli S, Chen YY, Huppert LA, Church AL, Beckwith H, Carroll E, Solanki M, Borges VF, Tevis SEA, Chen N, Zeck JC, Kowzun MJ, Sullivan J, Marshall N, Klein ME, Giridhar KV, Acharya-Leon R, Fan B, Walsh EM, Litvak A, Jahan N, McDonald E, Douglas EH, Zena J, Guth A, Johnson K, McGuinness JE, Matsuda K, Shakeri S, Krishnamurthy J, Kang I, Madans A, Feldman S, Johnson M, Katerji H, Ma Y, Matthews JB, Delson AL, LeStage B, Perlmutter J, Petricoin EF, Shatsky RA, Price E, Basu A, Asare AL, Helsten T, McNatt MH, Mukhtar RA, Symmans WF, Borowsky AD, Heshman DL, DeMichele AM, Rugo HS, Hylton NM, van 't Veer LJ, Esserman LJ. Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast Cancer: The I-SPY2.2 Randomized Clinical Trial. JAMA Oncol. 2026 Oct 22.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)